These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18328754)

  • 41. Predicting the predictability: a unified approach to the applicability domain problem of QSAR models.
    Dragos H; Gilles M; Alexandre V
    J Chem Inf Model; 2009 Jul; 49(7):1762-76. PubMed ID: 19530661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new computer program for QSAR-analysis: ARTE-QSAR.
    Van Damme S; Bultinck P
    J Comput Chem; 2007 Aug; 28(11):1924-8. PubMed ID: 17394240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
    Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M
    ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mathematical programming assisted drug design for nonclassical antifolates.
    Garg S; Achenie LE
    Biotechnol Prog; 2001; 17(3):412-8. PubMed ID: 11386859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A segmented principal component analysis-regression approach to quantitative structure-activity relationship modeling.
    Hemmateenejad B; Elyasi M
    Anal Chim Acta; 2009 Jul; 646(1-2):30-8. PubMed ID: 19523553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ChemModLab: a web-based cheminformatics modeling laboratory.
    Hughes-Oliver JM; Brooks AD; Welch WJ; Khaledi MG; Hawkins D; Young SS; Patil K; Howell GW; Ng RT; Chu MT
    In Silico Biol; 2011-2012; 11(1-2):61-81. PubMed ID: 22475752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
    Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
    J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recursive partitioning for the prediction of cytochromes P450 2D6 and 1A2 inhibition: importance of the quality of the dataset.
    Burton J; Ijjaali I; Barberan O; Petitet F; Vercauteren DP; Michel A
    J Med Chem; 2006 Oct; 49(21):6231-40. PubMed ID: 17034129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling the activity of furin inhibitors using artificial neural network.
    Worachartcheewan A; Nantasenamat C; Naenna T; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Eur J Med Chem; 2009 Apr; 44(4):1664-73. PubMed ID: 18977558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antioxidant QSAR modeling as exemplified on polyphenols.
    Lucić B; Amić D; Trinajstić N
    Methods Mol Biol; 2008; 477():207-18. PubMed ID: 19082949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling robust QSAR 3: SOM-4D-QSAR with iterative variable elimination IVE-PLS: application to steroid, azo dye, and benzoic acid series.
    Bak A; Polanski J
    J Chem Inf Model; 2007; 47(4):1469-80. PubMed ID: 17567123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin sensitization: reaction mechanistic applicability domains for structure-activity relationships.
    Aptula AO; Patlewicz G; Roberts DW
    Chem Res Toxicol; 2005 Sep; 18(9):1420-6. PubMed ID: 16167834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mixed-model QSAR at the glucocorticoid receptor: predicting the binding mode and affinity of psychotropic drugs.
    Spreafico M; Ernst B; Lill MA; Smiesko M; Vedani A
    ChemMedChem; 2009 Jan; 4(1):100-9. PubMed ID: 19009570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.
    Roy K; Mitra I
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):450-74. PubMed ID: 21521150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unified QSAR and network-based computational chemistry approach to antimicrobials, part 1: multispecies activity models for antifungals.
    González-Díaz H; Prado-Prado FJ
    J Comput Chem; 2008 Mar; 29(4):656-67. PubMed ID: 17999385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Merging applicability domains for in silico assessment of chemical mutagenicity.
    Liu R; Wallqvist A
    J Chem Inf Model; 2014 Mar; 54(3):793-800. PubMed ID: 24494696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of methods for chemical-compound affinity prediction.
    Koike A
    SAR QSAR Environ Res; 2006 Oct; 17(5):497-514. PubMed ID: 17018425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of a pharmacophore-based QSAR model for the prediction of CNS activity.
    Gozalbes R; Barbosa F; Nicolaï E; Horvath D; Froloff N
    ChemMedChem; 2009 Feb; 4(2):204-9. PubMed ID: 19097128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment.
    Bouwman T; Cronin MT; Bessems JG; van de Sandt JJ
    Hum Exp Toxicol; 2008 Apr; 27(4):269-76. PubMed ID: 18684796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.